Business ❯ Pharmaceutical Industry

Generic Drugs

Market Competition Market Access Market Dynamics Market Regulation Market Trends Market Impact Biosimilars Market Launch Market Launches Manufacturing

Glenmark Agrees to $29.6 Million Multistate Settlement Over Generic-Drug Pricing

The settlement resolves allegations that the company conspired to inflate generic prices and creates a centralized claims process for consumers.

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

Supreme Court Skeptical of Expanding Inducement Liability in Skinny-Label Drug Case

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

India Tightens Oversight as Low‑Cost Semaglutide Hits Pharmacies

Semaglutide Patent Expires in Brazil, Opening Door to Lower-Cost Rivals

Semaglutide Patents Lapse in India and China as Safety Scrutiny Rises

India Readies Dozens of Semaglutide Generics as Ozempic Patent Nears Expiry

FDA Clears First Generic Flovent HFA Inhaler as Glenmark Prepares U.S. Launch

Canada Opens Path to Generic Ozempic as Health Canada Weighs Nine Applications

Brazil’s Superior Court of Justice Rejects Semaglutide Patent Extension, Paving Way for 2026 Generics

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

Gilead Starts Shipping Twice-Yearly HIV Prevention Shot to Eswatini and Zambia

FDA Proposes Faster Biosimilar Approvals by Dropping Routine Human Trials

California Sets Jan. 1, 2026 Launch for $11 CalRx Insulin Pens

South Africa Sets April 2026 Rollout for Twice-Yearly HIV-Prevention Shot, With Limited Early Supply

India Cough Syrup Crisis: Sresan Pharma Owner Detained as Tamil Nadu Confirms Toxic Contamination

France Restores 40% Cap on Generic-Drug Rebates Through Year-End After Pharmacists’ Protests

Deals Set $40 Generics of Twice-Yearly HIV Prevention Shot for 120 Countries by 2027

France Pauses Generic Discount Cuts for Three Months After Pharmacy Protests